GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (FRA:VP2) » Definitions » FCF Yield %

Valeo Pharma (FRA:VP2) FCF Yield % : -90.01 (As of May. 07, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Valeo Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Valeo Pharma's Trailing 12-Month Free Cash Flow is €-5.79 Mil, and Market Cap is €6.36 Mil. Therefore, Valeo Pharma's FCF Yield % for today is -90.01%.

The historical rank and industry rank for Valeo Pharma's FCF Yield % or its related term are showing as below:

FRA:VP2' s FCF Yield % Range Over the Past 10 Years
Min: -162.92   Med: -27.31   Max: -3.72
Current: -90.01


During the past 7 years, the highest FCF Yield % of Valeo Pharma was -3.72%. The lowest was -162.92%. And the median was -27.31%.

FRA:VP2's FCF Yield % is ranked worse than
93.72% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.64 vs FRA:VP2: -90.01

Valeo Pharma's FCF Margin % for the quarter that ended in Jan. 2024 was 11.68%.


Valeo Pharma FCF Yield % Historical Data

The historical data trend for Valeo Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma FCF Yield % Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
FCF Yield %
Get a 7-Day Free Trial - -12.58 -24.44 -67.36 -164.40

Valeo Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -91.95 -9.24 -19.62 -238.26 25.63

Competitive Comparison of Valeo Pharma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valeo Pharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's FCF Yield % falls into.



Valeo Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Valeo Pharma's FCF Yield % for the fiscal year that ended in Oct. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-14.675 / 8.92638605
=-164.40%

Valeo Pharma's annualized FCF Yield % for the quarter that ended in Jan. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=1.081 * 4 / 16.8720399
=25.63%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valeo Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Valeo Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeo Pharma (FRA:VP2) Business Description

Traded in Other Exchanges
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Valeo Pharma (FRA:VP2) Headlines

No Headlines